Abemaciclib can promote Caspase-3 overexpression, early apoptosis, and G1 arrest in Pancreatic ductal adenocarcinoma (PDAC) cells via down-regulating p-Rb [27]. Here, CASP3 is linked to pancreatic ductal adenocarcinoma.